Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides
Peptide-based nanoparticles (PBN) for nucleotide complexation and targeting of extrahepatic diseases are gaining recognition as potent pharmaceutical vehicles for fine-tuned control of protein production (up- and/or down-regulation) and for gene delivery. Herein, we review the principles and mechani...
Main Authors: | Samuel A. Wickline, Kirk K. Hou, Hua Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/11/9455 |
Similar Items
-
Chitosan Oleate Coated PLGA Nanoparticles as siRNA Drug Delivery System
by: Dalila Miele, et al.
Published: (2021-10-01) -
Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
by: Xueliang Yu, et al.
Published: (2021-11-01) -
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
by: Wanyi Tai
Published: (2019-06-01) -
Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
by: Xuan Du, et al.
Published: (2023-09-01) -
Hydrocarbon-Stapled Peptide Based-Nanoparticles for siRNA Delivery
by: Matthieu Simon, et al.
Published: (2020-11-01)